Compare Agilent Technologies Inc (A) vs Bumble Inc (BMBL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Bumble Inc — how do they compare? Agilent Technologies Inc trades at $148.72 (market cap $42.00B), while Bumble Inc trades at $2.77 (market cap $359.61M). The key difference: Agilent Technologies Inc is far larger — about 116.8× Bumble Inc's market cap, and Agilent Technologies Inc pays a 0.69% dividend while Bumble Inc pays none. Which is the better fit depends on your goals.
| A | BMBL | |
|---|---|---|
Market Cap | $42.00B | $359.61M |
Sector | Health | Technology |
52-Week High | $157.20 | $7.17 |
52-Week Low | $110.24 | $2.70 |
Enterprise Value | $43.55B | $665.47M |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Bumble (BMBL) trades at $2.83, down 0.53% with bearish technical signals. The company reported mixed Q2 2026 results, beating earnings estimates but missing on revenue with declining paying users. Despite a gross margin of 72.84%, Bumble shows negative profitability metrics with -57.96% net margin and -87.65% ROE. Recent news indicates strategic shifts toward IRL events and AI matchmaking amid exploration of potential sale options.
Outlook remains challenging with significant execution risks. While valuation multiples appear attractive (P/S 0.39, P/B 0.72), persistent user declines and negative cash flow create headwinds. Analyst consensus leans Hold (73.91%) with $3.62 price target suggesting 28% upside, but success hinges on product transformation reversing user trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Bumble Inc
Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come on a monthly basis to discover new people and connect with each other.
Read more on BMBL →
